首页 | 本学科首页   官方微博 | 高级检索  
     

Development and validation of a selective and robust LC-MS/MS method for quantifying trimetazidine in human plasma
引用本文:ZHOU Gan OUYANG Dong-sheng TAN Zhi-rong CHEN Yao GUO Dong LIU Ying-zi ZHOU Hong-hao. Development and validation of a selective and robust LC-MS/MS method for quantifying trimetazidine in human plasma[J]. 中国临床药理学与治疗学, 2007, 12(10): 1198-1199
作者姓名:ZHOU Gan OUYANG Dong-sheng TAN Zhi-rong CHEN Yao GUO Dong LIU Ying-zi ZHOU Hong-hao
作者单位:Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University, Changsha 410078, Hunan, China
摘    要:AIM: To develop and validate a liquid chromatography-tandem mass spectrometric method (LC-MS/MS) for quantifying trimetazidine in human plasma.METHODS: Sample preparation was based on extracted using acetonitrile only. Chromatography was performed on a C18 analytical column and the retention times were 1.9 and 2.6 min for trimetazidine and cetirizine (internal standard), respectively. The ionization was optimized using ESI ( + ) and enhanced selectivity was achieved using tandem mass spectrometric analysis via two MRM functions, m/z:267→m/z: 181 and m/z:389→m/z:201 for trimetazidine and cetirizine.[第一段]

关 键 词:LC-MS/MS 人血浆 曲美他嗪 浓度测定

Development and validation of a selective and robust LC-MS/MS method for quantifying trimetazidine in human plasma
Abstract:
Keywords:mass spectrometry   bioquivalence   trimetazidine
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号